Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Roche sets sights on July FDA ruling with updated eye drug data

One year on from a mixed phase 3 readout, Roche has shared updated data from eye disease trials that could support FDA approval by July.

Nick Paul Taylor Oct 12, 2026 9:42am

Tortugas’ schizophrenia drug proves worth in ph. 2 Hansoh trial

Oct 12, 2026 9:23am

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics

BMS doubles up with pivotal wins in lung disease, solid tumor

Oct 12, 2026 8:05am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

Merck data raise fears $1.3B eye drug has ‘limited’ potential

Oct 12, 2026 2:54am